Thus, tumor promoting ability of fibroblasts did not depend on their tissue source of origin (i.e. breast tumor or reduction mammoplasty, Table 1), nor did it associate with their extent of αSMA, FSP, FAP, or Caveolin-1 expression (Fig. 1 and Fig. S1A). This evidence concerns the gene CXCL1 and breast neoplasm.